A detailed history of Brandywine Global Investment Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 51,877 shares of AMGN stock, worth $14.9 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
51,877
Previous 333,867 84.46%
Holding current value
$14.9 Million
Previous $104 Million 83.98%
% of portfolio
0.12%
Previous 0.8%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$309.38 - $337.38 $87.2 Million - $95.1 Million
-281,990 Reduced 84.46%
51,877 $16.7 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $3.01 Million - $3.66 Million
11,468 Added 3.56%
333,867 $104 Million
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $710,085 - $857,162
-2,641 Reduced 0.81%
322,399 $91.7 Million
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $12.7 Million - $14.4 Million
-49,793 Reduced 13.28%
325,040 $93.6 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $12.3 Million - $15.3 Million
-56,253 Reduced 13.05%
374,833 $101 Million
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $27.9 Million - $32.9 Million
-130,029 Reduced 23.17%
431,086 $95.7 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $48.4 Million - $59 Million
214,512 Added 61.89%
561,115 $136 Million
Q4 2022

Feb 10, 2023

BUY
$229.03 - $291.01 $9.81 Million - $12.5 Million
42,820 Added 14.1%
346,603 $91 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $7.27 Million - $8.2 Million
-32,394 Reduced 9.64%
303,783 $68.5 Million
Q2 2022

Aug 11, 2022

BUY
$230.71 - $256.74 $25.2 Million - $28 Million
109,165 Added 48.09%
336,177 $81.8 Million
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $44.1 Million - $48.8 Million
201,232 Added 780.57%
227,012 $54.9 Million
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $35,599 - $40,740
-179 Reduced 0.69%
25,780 $5.8 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $98,917 - $115,894
-466 Reduced 1.76%
25,959 $5.52 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $110 Million - $122 Million
-468,967 Reduced 94.67%
26,425 $6.44 Million
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $6.87 Million - $8 Million
-30,953 Reduced 5.88%
495,392 $123 Million
Q4 2020

Feb 10, 2021

SELL
$216.38 - $257.67 $168,560 - $200,724
-779 Reduced 0.15%
526,345 $121 Million
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $19.9 Million - $22.2 Million
-84,917 Reduced 13.87%
527,124 $134 Million
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $4.08 Million - $5.01 Million
-20,645 Reduced 3.26%
612,041 $144 Million
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $1.87 Million - $2.48 Million
-10,253 Reduced 1.59%
632,686 $128 Million
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $744,730 - $957,235
-3,936 Reduced 0.61%
642,939 $154 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $10.2 Million - $12.3 Million
-58,725 Reduced 8.32%
646,875 $125 Million
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $751,983 - $881,494
4,511 Added 0.64%
705,600 $130 Million
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $14.3 Million - $16.2 Million
-79,218 Reduced 10.15%
701,089 $133 Million
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $3.48 Million - $4.07 Million
19,528 Added 2.57%
780,307 $152 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $6.34 Million - $7.15 Million
-34,205 Reduced 4.3%
760,779 $158 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $8.62 Million - $9.68 Million
51,889 Added 6.98%
794,984 $147 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $2.36 Million - $2.76 Million
13,945 Added 1.91%
743,095 $127 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $17.5 Million - $19.6 Million
103,941 Added 16.63%
729,150 $127 Million
Q3 2017

Nov 14, 2017

SELL
$167.29 - $191.0 $3.64 Million - $4.16 Million
-21,770 Reduced 3.36%
625,209 $117 Million
Q2 2017

Aug 14, 2017

BUY
N/A
646,979
646,979 $111 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Brandywine Global Investment Management, LLC Portfolio

Follow Brandywine Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.